Enterprise performance management in the pharmaceutical industry

Enterprise performance in the pharmaceutical industry

The pharmaceutical industry faces a number of key issues, such as rising healthcare costs, increasing research and development budgets and reimbursement pressures. In the face of such challenges, how can companies in this industry outperform their peers and maximise shareholder value?

Contact

Contact

Also on KPMG.com

ENTERPRISE PERFORMANCE MANAGEMENT IN THE PHARMACEUTICAL INDUSTRY

With a deep understanding of industry trends, KPMG’s Enterprise Performance Management (EPM) experts have helped companies outperform their peers through transforming their approach to three key EPM components.

Key components:

  • Planning, Budgeting and Forecasting: Translating strategy into plans that can be monitored and reviewed
  • Performance Reporting: Monitoring and reviewing performance against your plans 
  • Dimensional Profitability: Doing profitability and cost analysis to highlight opportunities to maximise shareholder value.

Connect with us

 

Request for proposal

 

Submit

KPMG’s new-look website

KPMG’s new-look website